Dr. Elizabeth Fabre, Oncologist at the Georges Pompidou European Hospital (AP-HP) describes how advances in personalized medicine are changing practices in the treatment of lung cancer.

Acute Myeloid Leukemia: identification of a new targeted therapy approach
Acute myeloid leukemia (AML) is a hematologic malignancy that develops from hematopoietic stem
